KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Zichang,Dai

第一单位： Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, P. R. China.

作者： Zichang,Dai ^[1] ; Qiyuan,Huang ^[2] ; Xueran,Huang ^[3] ; Chuiyu,Zhu ^[2] ; Kashif Rafiq,Zahid ^[1] ; Tiancai,Liu ^[4] ; Qiuyan,Li ^[5] ; Chunmei,Wu ^[2] ; Minghui,Peng ^[2] ; Xiangyan,Xiao ^[2] ; Umar,Raza ^[2] ; Nan,Yu ^[6] ; Tao,Zeng ^[1]

作者单位： Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, P. R. China. ^[1] Department of Medical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, P. R. China. ^[2] Department of Clinical Biobank Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China. ^[3] Department of Radiation Oncology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA. ^[4] Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, P. R. China. ^[5] Department of Biological Sciences, PWD Campus, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan. ^[6]

关键词 EMT KIN17 Smad2 TGF-beta hepatocellular carcinoma invasion metastasis migration